Burosumab for CSHS

NCT03993821 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

UNKNOWN

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Skeletal Hypophosphatemia Syndrome (CSHS)
Epidermal Nevus Syndrome

Interventions

DRUG: Burosumab

Sponsor

Laura Tosi

Collaborators

[object Object]
[object Object]